Table 3. Demographic, clinical and brain imaging profile of the subjects enrolled.
| MTLE (n = 30) | Control (n = 30) | ||
|---|---|---|---|
| Male (n = 18) | Age (mean ± SD)* | 25.28 ± 11.75 | 28.17 ± 13.96 |
| Female (n = 12) | Age (mean ± SD)* | 33.33 ± 14.28 | 35.83 ± 11.19 |
| Seizure type | dyscognitive seizures | 1 (3.33%) | |
| Automation | 7 (23.33%) | ||
| generalized tonic-clonic seizures (GTCS) | 7 (23.33%) | ||
| GTCS + dyscognitive seizures | 1 (3.33%) | ||
| GTCS + automation | 9 (30.00%) | ||
| dyscognitive seizures + automation | 4 (13.33%) | ||
| GTCS + dyscognitive seizures + automation | 1 (3.33%) | ||
| Aura | None | 12 (40.00%) | |
| Affective | 1 (3.33%) | ||
| Epigastric | 7 (23.33%) | ||
| Cephalic | 4 (13.33%) | ||
| Palpitations | 3 (10.00%) | ||
| Visual | 2 (6.67%) | ||
| Inter-ictal EEG | Left temporal | 10 (33.33%) | |
| Right temporal | 11 (36.67%) | ||
| Bilateral temporal | 9 (30.00%) | ||
| MRI | Normal | 14 (46.67%) | |
| Hippocampal sclerosis | 9 (30.00%) | ||
| Encephalomal acia foci | 1 (3.33%) | ||
| Lacunar infarction | 4 (13.33%) | ||
| Encephalomal atrophy | 2 (6.67%) | ||
| Seizure frequency | >Once per week | 8 (26.67%) | |
| Once per week to month | 6 (20.00%) | ||
| Once per month to 6 months | 10 (33.33%) | ||
| <once per year | 6 (20.00%) | ||
| Disease duration | <10 years | 10 (33.33%) | |
| ≥10 years | 20 (66.67%) | ||
| Age of first onset | Within 1 year | 1 (3.33%) | |
| 1–12 years | 9 (30.00%) | ||
| >12 years | 20 (66.67%) |
*P > 0.05 between the patient and control groups by Student-t test.